Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndrome

Clinical and Experimental Rheumatology

Volumn 31, Issue 1, 2013, Pages 103-110

  Brito Zerón, Pilar ^a   Akasbi, Miriam ^a,c   Bosch, Xavier ^b   Bové, Albert ^a   Pérez De Lis, Marta ^d   Diaz Lagares, Candido ^a   Retamozo, Soledad ^a   Gandía, Myriam ^e   Pérez Alvarez, Roberto ^d   Soto Cárdenas, Ma José ^e   Sisó, Antoni ^a   Valls Sole, Josep ^a   Graus, Francesc ^a   Ramos Casals, Manuel ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b ICMiD ^*  (Spain)

^c HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^d HOSPITAL DO MEIXOEIRO   (Spain)

^e HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Focal nerve entrapment; Neuronopathy; Peripheral neuropathy; Primary Sj gren's syndrome; Vasculitis

Indexed keywords

ADULT; ARTICLE; AXONAL SENSORIMOTOR POLYNEUROPATHY; CONTROLLED STUDY; DEMYELINATING POLYRADICULONEUROPATHY; DISEASE CLASSIFICATION; ELECTRODIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONEUROPATHY; MONONEUROPATHY MULTIPLEX; NERVE CONDUCTION; NEUROPATHY; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSORY NEURONOPATHY; SJOEGREN SYNDROME; SURVIVAL TIME;

AGED; CHI-SQUARE DISTRIBUTION; DISABILITY EVALUATION; ELECTROMYOGRAPHY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEURAL CONDUCTION; NEUROLOGIC EXAMINATION; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; SJOGREN'S SYNDROME; SPAIN;

EID: 84874891158     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X: Primary Sjögren syndrome: from suspicion to diagnosis. BMJ 2012 (in press).
2. Kassan SS, Moutsopoulos HM: Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 2004;164:1275-1284.
3. Ramos-Casals M, Tzioufas AG, Font J: Primary Sjögren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 2005;64:347-354.
4. Ramos-Casals M, Solans R, Rosas J et al.; Gemess Study Group: Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine 2008;87:210-219.
5. Pavlakis PP, Alexopoulos H, Kosmidis ML et al.: Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry 2011;82:798-802.
6. England JD, Asbury AK: Peripheral neuropathy. Lancet 2004;363:2151-2161.
7. Ramos-Casals M, Font J: Primary Sjögren syndrome. In "Current Diagnosis & Treatment in Rheumatology", Eds. IMBODEN J, HELLMAN D, STONE JH, Editorial McGraw-Hill, New York 2007, pp 237-245.
8. Malinow K, Yannakakis GD, Glusman SM et al.: Subacute sensory neuronopathy secondary to dorsal root ganglionitis in primary Sjögren's syndrome. Ann Neurol 1986;20:535-537.
9. Graus F, Pou A, Kanterewicz E, Anderson NE: Sensory neuronopathy and Sjögren's syndrome: clinical and immunologic study of two patients. Neurology 1988;38:1637-9.
10. Font J, Ramos-Casals M, De La Red G et al.: Pure sensory neuropathy in primary Sjögren's syndrome. Longterm prospective followup and review of the literature. J Rheumatol 2003;30:1552-1557.
11. Font J, Valls J, Cervera R, Pou A, Ingelmo M, Graus F: Pure sensory neuropathy in patients with primary Sjögren's syndrome: clinical, immunological, and electromyographic findings. Ann Rheum Dis 1990;49:775-778.
12. Delalande S, De Seze J, Fauchais AL et al.: Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine 2004;83:280-291.
13. Sène D, Jallouli M, Lefaucheur JP et al.: Peripheral neuropathies associated with primary Sjögren syndrome: immunologic profiles of nonataxic sensory neuropathy and sensorimotor neuropathy. Medicine 2011;90:133-138.
14. Seror R, Ravaud P, Bowman SJ et al.; Eular Sjögren'S Task Force: Eular Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome. Ann Rheum Dis 2010;69:1103-1109.
15. Hughes R: Peripheral nerve diseases: the bare essentials. Pract Neurol 2008;8:396-405.
16. England JD, Gronseth GS, Franklin G et al.; American Academy of Neurology; American Association of Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005;64:199-207.
17. Casanova-Molla J, Morales M, Solà-Valls N et al.: Axonal fluorescence quantitationprovides a new approach to assess cutaneous innervation. J Neurosci Methods 2011;200:190-198.
18. Bamford J, Sandercock P, Dennis M et al.: A prospective study of acute cerebrovascular disease in the community. J Neurol Neurosurg Psychiatry 1988;51:1373-1380.
19. Martyn CN, Hughes RA: Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997;62:310-318.
20. Grant IA, Hunder GG, Homburger HA, Dyck PJ: Peripheral neuropathy associated with sicca complex. Neurology 1997;48:855-862.
21. Mori K, Iijima M, Koike H et al.: The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 2005;128:2518-2534.
22. Valls-Sole J, Graus F, Font J, Pou A, Tolosa ES: Normal proprioceptive trigeminal afferents in patients with Sjögren's syndrome and sensory neuronopathy. Ann Neurol 1990;28:786-790.
23. Takahashi Y, Takata T, Hoshino M, Sakurai M, Kanazawa I: Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjögren's syndrome. IV immunoglobulin. Neurology 2003;60:503-505.
24. Rist S, Sellam J, Hachulla E et al.; On The Behalf The Club Rhumatismes Et Inflammation: Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjögren's syndrome: A national multicentric retrospective study. Arthritis Care Res (Hoboken) 2011;63:1339-1344.
25. Ramos-Casals M, García-Hernández FJ, De Ramón E et al.; Biogeas Study Group: Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases. Clin Exp Rheumatol 2010;28:468-476.
26. Botez SA, Herrmann DN: Prolonged remission of a demyelinating neuropathy in a patient with lymphoma and Sjögren's syndrome after Rituximab therapy. J Clin Neuromuscul Dis 2010; 11: 127-131.
27. Ramos-Casals M, Brito-Zerón P, Bové A, Sisó-Almirall A: Sjögren syndrome: Beyond sicca involvement. In: Autoimmune Diseases: Acute and Complex Situations, Khamashta MA, Ramos-Casals M (Eds.); Editorial Springer-Verlag, London 2011, pp 45-66.
28. Ramos-Casals M, Tzioufas AG, Stone JH, Sisó A, Bosch X: Treatment of primary Sjögren syndrome: a systematic review. JAMA 2010;304:452-460.